Conwell J, Katz D
BJA Educ. 2024; 24(11):426-432.
PMID: 39620101
PMC: 11602663.
DOI: 10.1016/j.bjae.2024.06.005.
Wiszniewska M, Wlodarczyk U, Sury M, Slomka A, Piekus-Slomka N, Zdanowicz A
Neurol Int. 2024; 16(3):551-560.
PMID: 38804480
PMC: 11130863.
DOI: 10.3390/neurolint16030041.
Kisioglu B, Tamer F
J Nutr Sci. 2024; 13:e18.
PMID: 38572365
PMC: 10988153.
DOI: 10.1017/jns.2024.11.
Kaserer A, Castellucci C, Henckert D, Breymann C, Spahn D
Transfus Med Hemother. 2023; 50(3):245-255.
PMID: 37435001
PMC: 10331157.
DOI: 10.1159/000528390.
Badescu M, Butnariu L, Costache A, Gheorghe L, Seritean Isac P, Chetran A
Life (Basel). 2023; 13(6).
PMID: 37374153
PMC: 10300874.
DOI: 10.3390/life13061371.
Profibrinolytic effects of rivaroxaban are mediated by thrombin-activatable fibrinolysis inhibitor and are attenuated by a naturally occurring stabilizing mutation in enzyme.
Garabon J, Boffa M
J Thromb Thrombolysis. 2023; 56(2):283-290.
PMID: 37310666
DOI: 10.1007/s11239-023-02837-3.
Sustaining Life versus Altering Life-Saving Drugs: Insights to Explain the Paradoxical Effect of Extracorporeal Membrane Oxygenation on Drugs.
Abidi E, El Nekidy W, Atallah B, Al Zaman K, Ghisulal P, El Lababidi R
J Clin Med. 2023; 12(11).
PMID: 37297946
PMC: 10253730.
DOI: 10.3390/jcm12113748.
RNAi for the Treatment of People with Hemophilia: Current Evidence and Patient Selection.
Boyce S, Rangarajan S
J Blood Med. 2023; 14:317-327.
PMID: 37123985
PMC: 10132380.
DOI: 10.2147/JBM.S390521.
Haemophilia A: A Review of Clinical Manifestations, Treatment, Mutations, and the Development of Inhibitors.
Sarmiento Doncel S, Diaz Mosquera G, Cortes J, Agudelo Rico C, Meza Cadavid F, Pelaez R
Hematol Rep. 2023; 15(1):130-150.
PMID: 36810557
PMC: 9944491.
DOI: 10.3390/hematolrep15010014.
Total Hip Arthroplasty Patients with Distinct Postoperative Fibrinolytic Phenotypes Require Different Antifibrinolytic Strategies.
Liu J, Chen B, Wu X, Wang H, Zuo X, Lei Y
J Clin Med. 2022; 11(23).
PMID: 36498472
PMC: 9736050.
DOI: 10.3390/jcm11236897.
The Vascular Endothelium and Coagulation: Homeostasis, Disease, and Treatment, with a Focus on the Von Willebrand Factor and Factors VIII and V.
De Pablo-Moreno J, Serrano L, Revuelta L, Sanchez M, Liras A
Int J Mol Sci. 2022; 23(15).
PMID: 35955419
PMC: 9425441.
DOI: 10.3390/ijms23158283.
Damage control in the intensive care unit: what should the intensive care physician know and do?.
Vargas M, Garcia A, Caicedo Y, Parra M, Ordonez C
Colomb Med (Cali). 2021; 52(2):e4174810.
PMID: 34908625
PMC: 8634272.
DOI: 10.25100/cm.v52i2.4810.
Evaluation of latest viscoelastic coagulation assays in the transcatheter aortic valve implantation setting.
Fanning J, Roberts S, Merza M, Anstey C, Poon K, Incani A
Open Heart. 2021; 8(1).
PMID: 33879508
PMC: 8061803.
DOI: 10.1136/openhrt-2020-001565.
Inflammatory Biomarkers in the Short-Term Prognosis of Venous Thromboembolism: A Narrative Review.
Galeano-Valle F, Ordieres-Ortega L, Oblitas C, Del-Toro-Cervera J, Alvarez-Sala-Walther L, Demelo-Rodriguez P
Int J Mol Sci. 2021; 22(5).
PMID: 33807848
PMC: 7961591.
DOI: 10.3390/ijms22052627.
Serpins in Hemostasis as Therapeutic Targets for Bleeding or Thrombotic Disorders.
Bianchini E, Auditeau C, Razanakolona M, Vasse M, Borgel D
Front Cardiovasc Med. 2021; 7:622778.
PMID: 33490121
PMC: 7817699.
DOI: 10.3389/fcvm.2020.622778.
Computationally Driven Discovery in Coagulation.
Link K, Stobb M, Monroe D, Fogelson A, Neeves K, Sindi S
Arterioscler Thromb Vasc Biol. 2020; 41(1):79-86.
PMID: 33115272
PMC: 7769924.
DOI: 10.1161/ATVBAHA.120.314648.
Increased Pro-Thrombotic Platelet Activity Associated with Thrombin/PAR1-Dependent Pathway Disorder in Patients with Secondary Progressive Multiple Sclerosis.
Dziedzic A, Miller E, Bijak M, Przyslo L, Saluk-Bijak J
Int J Mol Sci. 2020; 21(20).
PMID: 33086557
PMC: 7589910.
DOI: 10.3390/ijms21207722.
Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO.
Chlebowski M, Baltagi S, Carlson M, Levy J, Spinella P
Crit Care. 2020; 24(1):19.
PMID: 31959232
PMC: 6971875.
DOI: 10.1186/s13054-020-2726-9.
Recent advances in computational modeling of fibrin clot formation: A review.
Yesudasan S, Averett R
Comput Biol Chem. 2019; 83:107148.
PMID: 31751883
PMC: 6918949.
DOI: 10.1016/j.compbiolchem.2019.107148.
Increased perihematomal neuron autophagy and plasma thrombin-antithrombin levels in patients with intracerebral hemorrhage: An observational study.
Wu C, Yan X, Liao Y, Liao L, Huang S, Zuo Q
Medicine (Baltimore). 2019; 98(39):e17130.
PMID: 31574813
PMC: 6775380.
DOI: 10.1097/MD.0000000000017130.